Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 273,063 shares of SLS stock, worth $319,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,063
Previous 245,603
11.18%
Holding current value
$319,483
Previous $260,000
5.77%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SLS
# of Institutions
35Shares Held
8.03MCall Options Held
2.52MPut Options Held
24.7K-
Anson Funds Management LP Dallas, TX4.83MShares$5.65 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.77 Million0.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$360,9053.71% of portfolio
-
Black Rock Inc. New York, NY278KShares$325,5150.0% of portfolio
-
Opus Capital Group, LLC201KShares$234,7020.03% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...